Court Declares Medical Cannabis Company Bedrocan’s Dutch Entities Bankrupt

The Dutch entities of medical cannabis company Bedrocan have been declared bankrupt by a Dutch court, and the products it has supplied since 2003 to the government’s medical cannabis program will no longer be delivered, Forbes reports. The company had sought a suspension of payments in September and was declared bankrupt by the District Court of Northern Netherlands last week. 

Bedrocan’s supply contract with the Dutch government had ended in January after the government planned to change how medicinal cannabis is supplied, moving toward a less centralized market. The plan would amend the Opium Act – which regulates cannabis and controlled substances – and effectively end the Office of Medicinal Cannabis’s (OMC) trading monopoly and allow licensed companies to supply pharmacies under a new system expected in July 2028.  

Bedrocan’s bankruptcy now leaves about 7,000 Dutch medical cannabis patients with uncertainty. While OMC does have limited stock, patients have relied on specific cannabis strains – including Bedrocan’s – for years.  

The bankruptcy covers only Bedrocan’s Dutch entities, Bedrocan Nederland B.V. and Bedrocan International B.V. Its Danish and Canadian subsidiaries sit outside the filing, and it still supplies cannabis to the medical cannabis programs of Denmark, Italy, and Germany.